EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 31 January 2016. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 3.39 for October-December, 2015 as against Tk. 2.45 for October-December, 2014; Consolidated EPS was Tk. 9.48 for April-December, 2015 as against Tk. 6.77 for April-December, 2014. Consolidated NOCFPS was Tk. 12.59 for April-December, 2015 as against Tk. 7.75 for April-December, 2014. Consolidated NAV per share was Tk. 56.86 as of December 31, 2015 and Tk. 49.86 as of March 31, 2015.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf2d5a6b000040062acc
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.